Inventor · disambiguated record
Ofer Lider
Also filed as: LIDER OFER
12 granted patents·5 pending applications·243 citations·filing 1992–2014
92Inventor score
Top patents by PatentIndex Score
17 records- 0184US5474987AMethods of using low molecular weight heparins treatment of pathological processesYEDA RES & DEV·Filed 1995·Granted Dec 12, 1995·55 cites·6 claims
- 0281US5352667ANon-peptidic surrogates of the Arg-Gly-Asp sequence and pharmaceutical compositions comprising themLIDER OFER·Filed 1992·Granted Oct 4, 1994·59 cites·16 claims
- 0377US6750207B1Compositions for the regulation of cytokine activityYEDA RES & DEV·Filed 2000·Granted Jun 15, 2004·6 cites·5 claims
- 0474US6020323ACompositions and methods for regulation of active TNF-αYEDA RES & DEV·Filed 1995·Granted Feb 1, 2000·31 cites·17 claims
- 0573US5519005AMethod of inhibition of cellular and molecular level biological interactions utilizing non-peptidic surrogates of the Arg-Gly-Asp sequenceYEDA RES & DEV·Filed 1994·Granted May 21, 1996·28 cites·11 claims
- 0670US7285536B2Anti-cancer therapeutic compoundsYEDA RES & DEV·Filed 2001·Granted Oct 23, 2007·2 cites·28 claims
- 0769US8691772B2HSP60, HSP60 peptides and T cell vaccines for immunomodulationCOHEN IRUN R·Filed 2006·Granted Apr 8, 2014·1 cites·6 claims
- 0868US5908837AMethods of using low molecular weight heparins for prevention or treatment of pathological processesYEDA RES & DEV·Filed 1997·Granted Jun 1, 1999·21 cites·12 claims
- 0963US7332480B2Compositions for the regulation of cytokine activityYEDA RES & DEV·Filed 2004·Granted Feb 19, 2008·0 cites·19 claims
- 1063US5686431AMethods of using low molecular weight heparins for treatment of pathological processesYEDA RES & DEV·Filed 1995·Granted Nov 11, 1997·16 cites·4 claims
- 1159US2007010484A1Method for treating or inhibiting the effects of injuries or diseases that result in neuronal degeneration and method for promoting neurogenesisYEDA RES & DEV·Filed 2006·Application pending·0 cites
- 1258US5861382AMethods for regulation of active TNF-αYEDA RES & DEV·Filed 1993·Granted Jan 19, 1999·9 cites·5 claims
- 1358US2007225251A1Method for Treating or Inhibiting the Effects of Injuries or Diseases that Result in Neuronal DegenerationEISENBACH-SCHWARTZ MICHAL·Filed 2004·Application pending·0 cites
- 1456US6906170B1Anti-inflammatory peptides derived from IL-2 and analogues thereofYEDA RES & DEV·Filed 1999·Granted Jun 14, 2005·15 cites·15 claims
- 1552US2014219979A1Hsp60, hsp60 peptides and t cell vaccines for immunomodulationYEDA RES & DEV·Filed 2014·Application pending·0 cites
- 1639US2008274998A1Disaccharide Molecules and Derivatives Thereof and Methods of Using SameYEDA RES & DEV·Filed 2005·Application pending·0 cites
- 1739US2008311103A1Anti-Inflammatory Peptides and Methods of Use ThereofYEDA RES & DEV·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ofer Lider files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →